Infectious Endocarditis: Shorter Antibiotic Treatment Study

We are investigating whether a shorter course of antibiotics is safe and effective for treating left-sided infectious endocarditis caused by specific bacteria. This study also looks at the potential cost benefits of this accelerated treatment.

≤3 monthsConfirmation phase (III)Monitoring phase (IV)No PlaceboInvestigational MedicinesInjectionCardiologyInfectious Diseases

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Cefotaxim Fresenius
Cefotaxim Fresenius is an antibiotic medicine used to treat serious bacterial infections, such as pneumonia, blood infections, and meningitis.
Ceftriaxon Fresenius Kabi
Ceftriaxon Fresenius Kabi is an antibiotic medicine used to treat a wide range of bacterial infections.
Cloxacillin Stragen
Cloxacillin Stragen is an antibiotic used to treat certain bacterial infections such as skin, bone, and chest infections.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Ampicillin
Ampicillin is an antibiotic substance used to treat various bacterial infections.
Benzylpenicillin Sodium
Benzylpenicillin sodium is an antibiotic substance used to treat various bacterial infections.
Cefotaxime
Cefotaxime is an antibiotic substance used to treat serious bacterial infections by stopping bacteria from growing.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Benzylpenicillin

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

A-Pen
Agenor
Agenorem

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Region Skane Skanes Universitetssjukhus
Departnetn of Infectious Diseases
Lund, Sweden
Sponsor: Region Skane
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.